Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenue
Operating expenses
Research and development	130,467	45,683	504,169	279,000
General and administrative	1,070,314	386,809	1,944,111	1,176,242
Total operating expenses	1,200,781	432,492	2,448,280	1,455,242
Loss from operations	(1,200,781)	(432,492)	(2,448,280)	(1,455,242)
Other income (expense)
Interest income	84,731	4,564	265,460	13,990
Interest expense		(21,652)		(63,167)
Accretion of debt discount				(58,438)
Total other income (expense)	84,731	(17,088)	265,460	(107,615)
Net loss	$ (1,116,050)	$ (449,580)	$ (2,182,820)	$ (1,562,857)
Basic and Diluted Loss per Common Share	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)
Weighted average number of common shares outstanding - basic and diluted	87,243,352	76,840,522	87,198,132	76,727,802